Seroprevalence of hepatitis B and C among oncology patients in Turkey

Journal of Health, Population and Nutrition

Volumn 29, Issue 6, 2011, Pages 652-655

  Kose, Sukran ^a   Olmezoglu, Ali ^b   Gozaydin, Ayhan ^c   Ece, Gulfem ^a  

^a TEPECIK EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Sanliurfa Education and Research Hospital   (Turkey)

Author keywords

Cancers; Hepatitis; Hepatitis B; Hepatitis B virus; Hepatitis C; Hepatitis C virus; Seroprevalence; Turkey

Indexed keywords

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY;

ARTICLE; BLOOD; BLOOD TRANSFUSION; COMORBIDITY; ENZYME IMMUNOASSAY; EPIDEMIOLOGY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; NEOPLASM; TURKEY (REPUBLIC);

BLOOD TRANSFUSION; COMORBIDITY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASMS; SEROEPIDEMIOLOGIC STUDIES; TURKEY;

EID: 84857499119     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Cheng AL, Hsiung CA, Su IJ, Chen PJ, Chang MC, Tsao CJ et al. Steroid free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology 2003;37:1320-8.
2. Duman Y, Kaysadu H, Tekerekoglu MS. Hepatit B virüsü infeksiyonunun seroprevalansi{dotless}. Inonu Univ Fakül Derg (J Inonu Univ Med Facul) 2009;16:243-5.
3. Mehmet D, Meliksah E, Serif Y, Gunay S, Tuncer O, Zeynep S. Prevalence of hepatitis B infection in the southeast region of Turkey: comparison of risk factors in rural and urban areas. Jpn J Infect Dis 2005; 58:15-9.
4. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C among blood donors over 16 years in Turkey. Eur J Epidemiol 2006;21:299-305.
5. European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatitis C virus infection. J Hepatol 2011;55:245-64.
6. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008;48:148-62.
7. Yazi{dotless}ci{dotless} Y, Demir N, Ci{dotless}narka H, Yi{dotless}lmaz H, Alti{dotless}ntaş N. Seroprevalences of HBV, HCV and HIV among healthcare workers of Trabzon Chest Diseases Hospital. Türk Hijyen ve Deneysel Biyoloji Dergisi (Turkish Bull Hyg Experiment Biol) 2010;67:27-32.
8. Perrillo RP. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001; 120:1009-22.
9. Tsai FC, Hsieh SC, Chen DS, Sheu JC, Chen DS. Reactivation of hepatitis B virus in rheumatologic patients receiving immunosuppressive agents. Dig Dis Sci 2006;51:1627-32.
10. Yeo W, Chan PK, Zhong S, Ho WM, Steinberg JL, Tam JS et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol 2000;62:299-307.
11. Steinberg JL, Yeo W, Zhong S, Chan JY, Tam JS, Chan PK et al. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role. J Med Virol 2000;60:249-55.
12. Hwang YY, Liang RH. Hepatitis C in haematological patients. Hepat Res Treat 2010;2010:961359.
13. Yeo W, Chan PK, Ho WM, Zee B, Lam KC, Lei KI et al. Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. J Clin Oncol 2004;22:927-34.
14. Kebudi R, Ayan I, Yílmaz G, Akící F, Görgün O, Badur S. Seroprevalence of hepatitis B, hepatitis C, and human immunodeficiency virus infections in children with cancer at diagnosis and following therapy in Turkey. Med Pediatr Oncol 2000;34:102-5.
15. Monteleone PM, Andrzejewski C, Kelleher JF. Prevalence of antibodies to hepatitis C virus in transfused children with cancer. Am J Pediatr Hematol Oncol 1994;16:309-13.
16. Demirkaya M, Sevinir B. Pediatrik onkoloji hastalari{dotless}nda hepatit B ve seroprevalansi{dotless}ni{dotless}n deǧişimi. Uludaǧ Üniver Ti{dotless}p Fakültesi Dergisi 2008;34:103-6.
17. Kocabas E, Aksaray N, Alhan E, A, Köksal F, Yarkin F. Hepatitis B and C virus infections in Turkish children with cancer. Eur J Epidemiol 1997;13:869-73.
18. Topeli A, Ozyi{dotless}lkan E, Ozyi{dotless}lkan O, Kars A, Firat D. Hepatitis markers in cancer patients. Microbiol Bull 1994;27:107-12.
19. Utkan G, Azap A, Muallaoǧlu S, Tokluoǧlu S, Durnali{dotless} AG, Arslan AY et al. Hepatitis B and C in cancer patients: case-control study. Int J Hematol Oncol 2006;16:103-7.
20. Malaguarnera M, Gargante MP, Risino C, Ranno S, Berretta M, Cannizzaro MA et al. Hepatitis C virus in elderly cancer patients. Eur J Int Med 2006;17:325-9.
21. Uzun K, Ali{dotless}ci{dotless} S, Özbay B, Gencer M, Irmak H. The incidence of hepatitis C virus in patients with lung cancer. Turkish Respiratory J 2002;3:91-3.
22. Eren OO, Artac M, Boruban MC, Yavas O, Arslan U, Basaranoglu M. Chemotherapy-induced hepatitis B virus reactivation in HBsAg positive cancer patients: a single center experience. Med Oncol 2009;26:386-92.
23. Lai TS. Hepatitis B infection in special populations. Hong Kong Med Diary 2009;14:16-8.